Yeast Brews Future Flu Vaccines

A groundbreaking method for manufacturing influenza vaccines using baker's yeast is under development, potentially replacing the century-old egg-based process. Researchers aim for vaccines that provide long-lasting, broad protection against various flu strains by targeting a stable viral protein, potentially rendering annual flu shots unnecessary. This yeast-based system could also be more cost-effective and rapid for large-scale production.

In parallel, experiments suggest that low-frequency electrical stimulation deep within the brain's motor thalamus can significantly improve speech and swallowing difficulties resulting from traumatic brain injury. Early trials indicate notable improvements in word intelligibility and muscle control, offering new hope for patients with these debilitating deficits.

Furthermore, studies in mice are reshaping the understanding of cardiac repair after heart attacks. New blood vessels that act as natural bypasses appear to grow primarily from capillaries, the body's smallest blood vessels, rather than from larger arteries as previously believed. This finding could lead to new therapeutic strategies for promoting heart function.